New Delhi, Aug. 19 -- Shares of the Gujarat-based pharmaceutical company, Lincoln Pharmaceuticals Ltd, have remained an ideal sell on rise stock after hitting a 52-week high of Rs.770 apiece on the NSE at the end of May 2026. The pharma stock has struggled to sustain gains above its May 2026 levels, but the Indian brokerage Angel One remains bullish on this Ahmedabad-headquartered pharmaceutical company.

The brokerage is convinced about the trend reversal in this pharma stock and has given a 'buy' tag with a 12-month target of Rs.845 apiece, around 39% higher than the current Lincoln Pharmaceuticals share price of Rs.608.

Highlighting the company's fundamentals, Angel One said that Lincoln Pharmaceuticals is an Ahmedabad-based branded-g...